Recovery in commercial vehicle sector solidly underway, with overall constraining factor in 2011 being industry's ability to build rather than truckers' demand for vehicles, finds ACT North American outlook

COLUMBUS, Indiana , May 12, 2011 (press release) – Improved demand across the entire heavy duty vehicle market is reflected in the most recently available data, according to ACT Research Co. (ACT). It is readily apparent that the stage has been set for a long run-up in demand across the medium duty and heavy duty truck and commercial trailer segments.

The most recent release of the ACT North American Commercial Vehicle OUTLOOK reflects solid fundamentals supporting the upcycle in the commercial vehicle market. These include improved fleet financial performance, some improvement in credit availability, as well as pent-up demand from long-delayed equipment replacements and upgrades across the entire fleet spectrum.

“While the pace of economic growth eased slightly in the first quarter of 2011, our forecast concludes that the US economy has shifted into a self-sustaining recovery mode”, said Sam Kahan, ACT’s chief economist. “The recovery in the commercial vehicle sector is solidly underway, and the overall constraining factor for 2011 might actually be the industry’s ability to build rather than truckers’ demand for vehicles,” added Kahan.

ACT is the worldwide leading publisher of new and used commercial vehicle (CV) industry data, market analysis and forecasting services for the North American market, as well as the U.S. tractor-trailer market and the China CV market. ACT’s CV services are used by all major North American truck and trailer manufacturers and their suppliers, as well as worldwide banking and investors. For more information on ACT, please visit

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.